News & Insights – Sempre Health

Prime Therapeutics and Sempre Health Expand Innovative Behavior-Based Pricing Model to Advance Patient Affordability

30 October, 2025

Following strong results with Blue Cross NC, Prime and Sempre expand availability of affordability and adherence solutions to commercial clients nationwide

Read more

News & Insights

Fierce Healthcare: Prime Therapeutics takes Sempre Health’s pricing model nationwide

30 October, 2025

Blues-backed pharmacy benefit manager Prime Therapeutics is expanding its partnership with Sempre Health nationwide after finding significant savings in a pilot program.

Read more

Prime Therapeutics expands Sempre Health partnership to rein in drug costs

30 October, 2025

Pharmacy benefit manager Prime Therapeutics is expanding its partnership with Sempre Health, a company that applies discounts at the pharmacy counter for people taking single-source drugs for chronic conditions.

Read more

Dr. John M. O’Brien Joins Sempre Board of Directors

27 October, 2025

Sempre Health welcomes Dr. John M. O’Brien, a recognized leader in health policy and pharmaceutical innovation, to its Board of Directors.

Read more

Sempre Health launches in-store savings notifications for patients, bringing discounts right to the pharmacy counter

04 September, 2025

New location-based savings alerts redefine the pharmacy visit and underscore Sempre Health’s ongoing commitment to medication adherence innovation

Read more

Building and Scaling a Platform Business in Healthcare

10 December, 2024

The Journal of the American College of Radiology features Sempre Health’s platform model that bridges pharma, health plans, and patients to improve medication access and adherence.

Read more

Perspectives on the pharmacy landscape with Mike Einodshofer

20 November, 2024

Sempre sat down with Michael Einodshofer whose deep experience in the pharmaceutical value chain gives him a unique perspective on the industry’s challenges. Read the full interview to learn more.

Read more

Get in touch to discuss
press

Contact us